Former VP at Thermo Fisher Scientific Inc
- Value proposition and utility of transfection reagents such as PEI (polyethylenimine) in C> (cell and gene therapy) workflows including in the manufacturing of viral vectors and in the transfection of cells
- Pros and cons of chemical transfection vs other transfection or transduction technologies including electroporation, LNPs (lipid nanoparticles), microfluidics and viral vectors
- Different types of transfection reagents and competitive positioning of incumbents including Polyplus, Polysciences, Mirus Bio, Thermo Fisher (NYSE: TMO) and Promega
- Demand outlook for transfection reagents and TAM expansion opportunities
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.